Other Global Peers |
SEATTLE GENETICS INC (NASDAQ), SINO BIOPHARM (HKEx), WUXI BIO (HKEx), BIOMARIN PHARMACEUTICAL (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), EXACT SCIENCES CORP (NASDAQ), BEIGENE (HKEx), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), MODERNA INC (NASDAQ), 10X GENOMICS INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), GENSCRIPT BIO (HKEx), REPLIGEN CORP (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), Lonza (SGX), CRISPR THERAPEUTICS AG (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), 3SBIO (HKEx), NEKTAR THERAPEUTICS (NASDAQ), ALKERMES PLC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), NATERA INC (NASDAQ), UNIQURE N.V. (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), DECIPHERA PHARMACEUTICALS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), XENCOR INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), HAOHAI BIOTEC (HKEx), EPIZYME INC (NASDAQ), REGENXBIO INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), ARVINAS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), VERACYTE INC (NASDAQ), VIELA BIO INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), NEXTCURE INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), FRONTAGE (HKEx), FATE THERAPEUTICS (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), CKLIFE SCIENCES (HKEx), VANDA PHARMACE INC (NASDAQ), VIVA BIOTECH (HKEx), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), ASCENTAGE-B (HKEx), INTREXON CORP (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), SYNTHORX INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), CORTEXYME INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), TG THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), OMEROS CORP (NASDAQ), KADMON HLDGS INC (NYSE), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), TRANSLATE BIO INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), RETROPHIN INC (NASDAQ), AVROBIO INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), CYTOKINETICS INC (NASDAQ), AGENUS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), SINOMAB BIO-B (HKEx), VOYAGER THERAPEUTICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), ASCLETIS-B (HKEx), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), MERUS B V (NASDAQ), XBIOTECH INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), DERMIRA INC (NASDAQ), ESSEX BIO-TECH (HKEx), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), ARDELYX INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), BELLUS HEALTH INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), ANAPTYSBIO INC (NASDAQ), RECRO PHARMA INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), MEDICINOVA INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), COMPUGEN (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), AVID BIOSERVICES INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), GERON CORP (NASDAQ), KAMADA (NASDAQ), PERSONALIS INC (NASDAQ), LEE'S PHARM (HKEx), CYTOMX THERAPEUTICS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), PFENEX INC (NYSE American), MANNKIND CORPORATION (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), DPHARMA (Bursa), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), XOMA CORP (NASDAQ), CHIASMA INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), ATHERSYS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), IVERIC BIO INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), CABALETTA BIO INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), AFFIMED N V (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), BBI LIFE SCI (HKEx), GALECTIN THERAPEUTICS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), ARAVIVE INC (NASDAQ), NANTKWEST INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), CHIMERIX INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), NANOVIRICIDES INC (NYSE American), IMV INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), ENZO BIOCHEM INC (NYSE), UNI-BIO GROUP (HKEx), FENNEC PHARMACEUTICALS INC (NASDAQ), SESEN BIO INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), CYMABAY THERAPEUTICS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), LINEAGE CELL THERAPEUTICS INC (NYSE American), NOVAVAX INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), 22ND CENTURY GROUP INC (NYSE American), VERASTEM INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), ADURO BIOTECH INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), INFLARX N V (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), OTONOMY INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), SYNLOGIC INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), CEL-SCI CORP (NYSE American), VERMILLION INC (NASDAQ), VACCINEX INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), COHBAR INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), EQUILLIUM INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), TREVENA INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), INMUNE BIO INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), CURIS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), RESTORBIO INC (NASDAQ), SAVARA INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), ORGENESIS INC (NASDAQ), CT ENTERPRISE (HKEx), PORT (SET), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), ARMATA PHARMACEUTICALS INC (NYSE American), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), BIOSINO BIO-TEC (HKEx), DIAMEDICA THERAPEUTICS INC (NASDAQ), EVOGENE LTD (NASDAQ), ISORAY INC (NYSE American), OUTLOOK THERAPEUTICS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), ZAFGEN INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), REGENT PACIFIC (HKEx), SEELOS THERAPEUTICS INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), ORAGENICS INC (NYSE American), BIOCARDIA INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), IBIO INC (NYSE American), SOLIGENIX INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), EXTRAWELL PHAR (HKEx), INDIA GLOBALIZATION CAPITAL INC (NYSE American), UNUM THERAPEUTICS INC (NASDAQ), ACTINIUM PHARMACEUTICALS INC (NYSE American), AZURRX BIOPHARMA INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), ADVAXIS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), ATYR PHARMA INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), SENESTECH INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), TOCAGEN INC (NASDAQ), VAXART INC (NASDAQ), PRECIPIO INC (NASDAQ), OCUGEN INC (NASDAQ), Suntar Eco-City^ (SGX), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), BIOCEPT INC (NASDAQ), SOPHIRIS BIO INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), TROVAGENE INC (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), NOVABAY PHARMACEUTICALS INC (NYSE American), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), MEGASUN (Bursa), TRILLIUM THERAPEUTICS INC (NASDAQ), BENITEC BIOPHARMA LTD SPON ADS EA REPR 200 ORD SHS(POST SPLIT) (NASDAQ), MGRC (Bursa), HAO WEN HLDGS (HKEx), XENETIC BIOSCIENCES INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), OPGEN INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), QT Vascular (SGX), DIFFUSION PHARMACEUTICALS INC (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), AIM IMMUNOTECH INC (NYSE American), AURIS MEDICAL HOLDING LTD (NASDAQ), SPHERIX INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ) |